MedPath

回音必集团江西东亚制药有限公司

Ownership
-
Established
2005-08-10
Employees
-
Market Cap
-
Website
www.sikongshan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

101

NMPA:101

Drug Approvals

Procaine Hydrochloride Injection

Product Name
盐酸普鲁卡因注射液
Approval Number
国药准字H20043279
Approval Date
Feb 23, 2023
NMPA

Procaine Hydrochloride Injection

Product Name
盐酸普鲁卡因注射液
Approval Number
国药准字H20043278
Approval Date
Feb 23, 2023
NMPA

Dextran 40 Sodium Chloride Injection

Product Name
右旋糖酐40氯化钠注射液
Approval Number
国药准字H36020305
Approval Date
Aug 4, 2022
NMPA

Clindamycin Phosphate and Sodium Chloride Injection

Product Name
克林霉素磷酸酯氯化钠注射液
Approval Number
国药准字H20067034
Approval Date
Jul 17, 2022
NMPA

Clindamycin Phosphate and Sodium Chloride Injection

Product Name
克林霉素磷酸酯氯化钠注射液
Approval Number
国药准字H20000624
Approval Date
Jul 17, 2022
NMPA

Aceglutamide and Glucose Injection

Product Name
德益芬
Approval Number
国药准字H20040838
Approval Date
Jul 17, 2022
NMPA

Compound Amino Acid Injection(14AA)

Product Name
复方氨基酸注射液(14AA)
Approval Number
国药准字H19993214
Approval Date
Jul 17, 2022
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H36020155
Approval Date
Jul 17, 2022
NMPA

Compound Sodium Lactate Injection

Product Name
复方乳酸钠注射液
Approval Number
国药准字H36022383
Approval Date
Jul 17, 2022
NMPA

Cisplatin and Sodium Chloride Injection

Product Name
顺铂氯化钠注射液
Approval Number
国药准字H20084385
Approval Date
Jul 17, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.